CorMedix Inc.
CRMD
$6.10
-$0.20-3.18%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 43.47M | 12.26M | 806.10K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.47M | 12.26M | 806.10K | -- | -- |
| Cost of Revenue | 3.19M | 2.01M | 1.33M | 818.50K | -- |
| Gross Profit | 40.28M | 10.25M | -522.20K | -818.50K | -- |
| SG&A Expenses | 58.70M | 56.70M | 51.18M | 43.24M | 35.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 65.83M | 63.22M | 58.95M | 54.64M | 48.96M |
| Operating Income | -22.36M | -50.96M | -58.14M | -54.64M | -48.96M |
| Income Before Tax | -19.32M | -47.54M | -54.51M | -51.63M | -46.34M |
| Income Tax Expenses | -1.39M | -1.39M | -1.39M | -1.39M | -- |
| Earnings from Continuing Operations | -17.93 | -46.15 | -53.12 | -50.24 | -46.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.93M | -46.15M | -53.12M | -50.24M | -46.34M |
| EBIT | -22.36M | -50.96M | -58.14M | -54.64M | -48.96M |
| EBITDA | -22.05M | -50.77M | -58.01M | -54.57M | -48.89M |
| EPS Basic | -0.33 | -0.80 | -0.93 | -0.93 | -0.92 |
| Normalized Basic EPS | -0.22 | -0.52 | -0.59 | -0.60 | -0.57 |
| EPS Diluted | -0.33 | -0.80 | -0.93 | -0.93 | -0.92 |
| Normalized Diluted EPS | -0.22 | -0.52 | -0.59 | -0.60 | -0.57 |
| Average Basic Shares Outstanding | 235.46M | 231.34M | 229.07M | 216.82M | 203.40M |
| Average Diluted Shares Outstanding | 235.46M | 231.34M | 229.07M | 216.82M | 203.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
